A cerebrospinal fluid microRNA signature as biomarker for glioblastoma
Oncotarget2017Vol. 8(40), pp. 68769–68779
Citations Over TimeTop 10% of 2017 papers
Johnny Akers, Wei Hua, Hongying Li, Valya Ramakrishnan, Zixiao Yang, Kai Quan, Wei Zhu, Jie Li, Javier Figueroa, Brian R. Hirshman, Brittney Miller, David Piccioni, Florian Ringel, Ricardo J. Komotar, Karen Messer, Douglas Galasko, Fred H. Hochberg, Ying Mao, Bob S. Carter, Clark C. Chen
Abstract
We report a CSF miRNA signature as a "liquid biopsy" diagnostic platform for glioblastoma.
Related Papers
- → Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients(2021)77 cited
- → “Sample-to-Answer” Detection of Rare ctDNA Mutation from 2 mL Plasma with a Fully Integrated DNA Extraction and Digital Droplet PCR Microdevice for Liquid Biopsy(2020)57 cited
- → Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer(2023)33 cited
- → Detection and quantification of EGFR T790M mutation in liquid biopsies by droplet digital PCR(2021)29 cited
- → Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients(2018)22 cited